Adriamycin

UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy

Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment

A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer

2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy

Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study

A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors

A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma

Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy

UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

Nivolumab and AVD in Early-stage Unfavorable Classical Hodgkin Lymphoma

Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor

Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99)

Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients

Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer

Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD